Interaction between human peripheral blood monocytes and tumor promoters: effect on growth differentiation and function in vitro.
Studies on the differentiation and activation of human monocytes in tissue cultures have usually been limited by the deterioration of human monocytes and macrophages in long-term cultures. In this study, we attempted to establish long-term human monocyte/macrophage cultures using the phorbol ester 12-0 tetradecanoyl-phorbol-13-acetate (TPA), and we studied the morphology, function, and biochemical properties of such treated human blood monocytes. Enriched suspensions of monocytes were obtained using Ficoll-Hypaque gradient and cultured in the absence or presence of various concentrations of TPA. Samples were removed at different times and processed for scanning electron microscopy. Parallel samples were examined for numbers of adherent cells, phagocytosis, oxidative burst, beta-galactosidase assays, and lectin-mediated erythrolysis. TPA-treated monocytes survived in larger numbers in culture for up to 7 weeks and were more pleomorphic and exhibited higher beta-galactosidase activities after 14 days in culture than untreated monocytes. TPA-treated cells and untreated cells in long-term cultures showed a decrease in their oxidative burst activity while their phagocytic activity was not affected, and the TPA treatment augmented the lysis of wheat germ agglutinin-opsonized erythrocytes by the cultured monocytes. TPA treatment of adherent human monocytes resulted in cell cultures with increased numbers of viable and functionally adherent cells for extended periods of time and does not seem to interfere with the differentiation and maturation of the cells in culture.
Keisari
Y
Y
Department of Human Microbiology, Sackler Faculty of Medicine, Tel Aviv University, Israel.
Bucana
C
C
Markovich
S
S
Campbell
D E
DE
D002452:Cell Count / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured / Q000166:cytology / Q000187:drug effects*; D002860:Chromium Radioisotopes; D003208:Concanavalin A / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D004912:Erythrocytes; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism; D008722:Methods; D008855:Microscopy, Electron, Scanning; D009000:Monocytes / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D010587:Phagocytosis / Q000187:drug effects; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*; D014909:Wheat Germ Agglutinins / Q000494:pharmacology; D001616:beta-Galactosidase / Q000378:metabolism
D002860:Chromium Radioisotopes; D014909:Wheat Germ Agglutinins; D003208:Concanavalin A; D006861:Hydrogen Peroxide; D001616:beta-Galactosidase; D013755:Tetradecanoylphorbol Acetate